Black Rock Inc. Kronos Bio, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 874,102 shares of KRON stock, worth $830,396. This represents 0.0% of its overall portfolio holdings.

Number of Shares

874,102

Previous 909,450 3.89%

Holding current value

$830,396

Previous $1.18 Million 8.38%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.73 - $1.38 $25,804 - $48,780	-35,348 Reduced 3.89%	874,102 $1.08 Million
Q1 2024 May 10, 2024	SELL	$1.02 - $1.3 $162,235 - $206,770	-159,054 Reduced 14.89%	909,450 $1.18 Million
Q4 2023 Feb 13, 2024	SELL	$0.75 - $1.49 $234,636 - $466,143	-312,848 Reduced 22.65%	1,068,504 $1.34 Million
Q3 2023 Nov 13, 2023	SELL	$1.23 - $2.25 $19,671 - $35,984	-15,993 Reduced 1.14%	1,381,352 $1.8 Million
Q2 2023 Aug 11, 2023	SELL	$1.24 - $1.92 $2.17 Million - $3.35 Million	-1,746,768 Reduced 55.56%	1,397,345 $2.4 Million
Q1 2023 May 12, 2023	SELL	$1.34 - $2.62 $84,114 - $164,462	-62,772 Reduced 1.96%	3,144,113 $4.59 Million
Q4 2022 Feb 13, 2023	SELL	$1.44 - $3.44 $373,730 - $892,800	-259,535 Reduced 7.49%	3,206,885 $5.2 Million
Q3 2022 Nov 14, 2022	SELL	$3.35 - $5.55 $134,619 - $223,026	-40,185 Reduced 1.15%	3,466,420 $11.6 Million
Q2 2022 Aug 12, 2022	BUY	$3.12 - $7.52 $327,210 - $788,660	104,875 Added 3.08%	3,506,605 $12.8 Million
Q1 2022 May 12, 2022	BUY	$6.26 - $14.42 $200,658 - $462,218	32,054 Added 0.95%	3,401,730 $24.6 Million
Q4 2021 Feb 10, 2022	BUY	$11.35 - $21.18 $4.96 Million - $9.26 Million	437,155 Added 14.91%	3,369,676 $45.8 Million
Q3 2021 Nov 09, 2021	BUY	$18.17 - $24.7 $2 Million - $2.72 Million	110,276 Added 3.91%	2,932,521 $61.5 Million
Q2 2021 Aug 11, 2021	BUY	$20.08 - $29.02 $56.7 Million - $81.9 Million	2,822,245 New	2,822,245 $67.6 Million

Others Institutions Holding KRON

# of Institutions

Shares Held

19.8M

Call Options Held

9.3K

Put Options Held

100

View Full List

About Kronos Bio, Inc.

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

More about KRON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account